Arthritis News - 2006

December

• Sleep Disturbance is Increased in Rheumatoid Arthritis
  12-15-06

November

• Risedronate not an Effective Disease Modifier in Knee Osteoarthritis

October

• ASSURE Trial Explores the Safety of Abatacept Therapy in RA
• Efficacy and Safety of Adalimumab with Ankylosing Spondylitis

September

• The IL-6 Receptor Antagonist Tocilizumab Shows Promise for the Treatment of RA
• Celecoxib Effective at Reducing Recurrent Colonic Adenomatous Polyps, but May Increase Cardiovascular Risk

August

• Temporal Trends in the Maintenance of Bone Health among Chronic Glucocorticoid Users Improving, but Fall Short of Recommendations
• Effectiveness of Combination Therapy vs. Monotherapy with Etanercept or Infliximab in “Real-World” Clinical Practice
• Osteoarthritis Initiative Releases First Data

July

• Ratio of Serum Osteoprotegerin and RANKL Predicts Radiographic Progression in RA

June

• Enbrel and Humira Now Have Automated Delivery System
• Abatacept in Methotrexate-Resistant RA Patients: AIM Trial Results Published
• Efficacy and Safety of Rituximab in Patients with Active Rheumatoid Arthritis: DANCER Trial Results Published
• Pregnancy Outcomes in Patients with Rheumatoid Arthritis and Lupus

May

• Risk Factors for Bisphosphonate Associated Jaw Osteonecrosis
• Is There an Increased Risk of Malignancy and Serious Infection Among RA patients Receiving High-dose Anti-TNF Therapy?
• Impact of RA Disease Activity and Treatment on the Risk of Developing Lymphoma
  

April

• Effect of Muscle-Derived Stem Cells on Cartilage Repair

March

• Predictors of Increased Carotid Atherosclerosis in RA Patients
  3-30-06
• Rituximab Receives FDA Approval for Treatment of Rheumatoid Arthritis
  3-1-06

February

• Results of GAIT Study Fail to Demonstrate Clinical Efficacy of Glucosamine or Chondroitin Sulfate in Symptomatic Knee Osteoarthritis
  2-24-06
• Ability of the PTPN22 1858C/T SNP to Predict RA Development
  2-14-06
• Interaction of environment, genetics and autoimmunity in the pathogenesis of rheumatoid arthritis (RA)
  2-8-06

January

• Efficacy of Adalimumab in Patients with Psoriatic Arthritis
  1-25-06

*Arthritis news summaries and editorials are written by Jon Giles, M.D., Joan Bathon, M.D., and Clifton O. Bingham, M.D. unless otherwise noted.

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.